Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2025-04-29 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return (FF305) related to changes in issued shares and treasury shares, including detailed repurchase and on‐market sale of treasury shares. It provides actual transaction details: number of shares repurchased, prices, opening/closing balances, and confirmations. This matches the definition of “Transaction in Own Shares” (share repurchase/issuance) rather than a capital issuance announcement or simple report publication. Therefore, the correct classification is POS.
2025-04-29 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 19, 2025
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a form of proxy for the upcoming Annual General Meeting, providing shareholders with voting instructions and proxy appointment details. This is a typical proxy solicitation document (materials sent to shareholders to provide information and request votes). It is not the AGM presentation itself, not the meeting results, and not a vote declaration. Therefore it should be classified as a Proxy Solicitation & Information Statement (PSI).
2025-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is titled “NOTICE OF ANNUAL GENERAL MEETING” and contains the agenda, resolutions, proxy instructions, meeting date, time, and location for the company’s upcoming annual general meeting. It does not include full financial statements or detailed performance data beyond what is necessary for the meeting notice. This is clearly AGM Materials rather than an Annual Report or other filing. Therefore, it is classified as AGM Information (AGM-R).
2025-04-28 English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; PROPOSED RE-APPOINTMENT OF AUDITOR&#x3b; PROPOSED AMENDMENTS TO THE M
Proxy Solicitation & Information Statement Classification · 96% confidence The document is a shareholder circular issued by Ocumension Therapeutics providing detailed information on proposed AGM resolutions (general mandates to issue and repurchase shares, re-election of directors, re-appointment of auditors, amendments to the Memorandum & Articles) and including the notice of the Annual General Meeting along with proxy voting instructions. It is not the meeting presentation nor the actual meeting minutes or results, nor is it a full annual report. It is exactly the materials sent to shareholders to solicit proxies and inform them about votes to be taken. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2025-04-28 English
2024 Environmental, Social and Governance Report
Environmental & Social Information Classification · 98% confidence The document is a comprehensive Environmental, Social, and Governance (ESG) report for the year 2024, with detailed sections on ESG governance, materiality assessment, stakeholder communication, ESG metrics, principles, and appendices. It follows the ESG Reporting Guide, covers environmental and social KPIs, and shows full report content rather than merely announcing publication. This matches the definition of Environmental & Social Information (ESG) Report (Code: SR).
2025-04-28 English
2024 Annual Report
Annual Report Classification · 100% confidence The document is clearly identified as an 'Annual Report' by its title, content structure (Chairman's Statement, Financial Summary, Management Discussion and Analysis, Independent Auditor's Report, and Consolidated Financial Statements), and the inclusion of comprehensive financial data for the fiscal year 2024. It is not an announcement of a report, but the full report itself. FY 2024
2025-04-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.